top of page
Contract Research

CONTRACT RESEARCH

BROAD THERAPEUTIC POTENTIAL

We work with our clients to deliver high-quality, unique and specialist biological engineering solutions for a sustainable future. 

Bondi’s platform technology can facilitate the manufacture & delivery of multiple therapeutic modalities into a range of organs, tissue and cells.

Our platform is versatile and modular, with potential utility across:

  • Nanoparticle-based vaccines

  • Nucleic acid delivery

  • Monoclonal Antibody production 

We are seeking to advance the latest ground-breaking biotherapies by partnering with drug-discovery and development experts to facilitate the cost-effective and reduced complexity manufacture of your biologics with our cyanobacteria platform. 

Using our unique end-to-end capabilities, including genetic design, biomanufacturing, downstream-processing, needle-free delivery and regulatory advancement, we’re looking for well-matched partners where we complement your expertise and can apply our novel approach to manufacture and deliver your latest therapeutic modalities.

Together, we want to develop, manufacture and deliver new medicines more quickly, more cost effectively and with more precision than ever before.

Bondi-2
Bondi-4
Bondi-5
Bondi-3
Technology
Co-creation

THERAPEUTIC CO-CREATION

CONTRACT RESEARCH METHODOLOGY

Partner with Bondi to co-create natural, clean, sustainable, and high-value therapeutic compounds. Our team will work with you to first Define, then Develop and ultimately Produce your target compounds.

Therapeutic Co-creation

DEFINE

Our engineering team will work with you to define your problem space, consider your specific scenario, and build a design specification for a solution that meets your requirements. We consider a wide range of parameters including target biologics, growth environment and end-use case.

DEVELOP

Having defined your design specification that addresses your problem space, we first prototype a proof-of-concept solution, before going through an extensive iterative strain development cycle, putting our high-throughput Cyanoworks™ platform to full-use, expanding and exploring the possible design space to repeatedly engineer and test improved-strains.

PRODUCE

Ultimately, we aim to provide robust, designer, photosynthetic organisms that produce your target ingredients at scale at your desired manufacturing location

We hope you will consider working with us and our engineering team here at Bondi, to Define, Develop and Produce your target therapeutic compounds.

Gene Therapies.jpeg

Applications

Read about applications we can assist with

About

About

Learn about our company

Technology

Technology

Learn more about our technology

bottom of page